Autopsy report · NCT00536991

Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer

“difficult to recruit”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months after it had already started.
• Ran for about 10 years before it stopped.
• 51 participants enrolled.
• Results were posted on the registry 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

Roswell Park Cancer Institute

Sponsor type

University, hospital or other

Conditions

Prostate Adenocarcinoma; Recurrent Prostate Carcinoma; Stage III Prostate Cancer; Stage IV Prostate Cancer

Interventions

Calcitriol; Ketoconazole; Laboratory Biomarker Analysis; Pharmacological Study; Therapeutic Hydrocortisone

Participants

51

Sites

1

Countries

United States

Trials that died the same way

• Comparison of 2 Different Positional Therapies for Positional Obstructive Sleep Apnea Syndrome
  “difficulties to recruit” (93% match in meaning)
• Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
  “Difficulty recruiting.” (90% match in meaning)
• Effectiveness Ankle-7 Orthosis VS HAFO Orthosis on Gait in Diplegic CPChildren
  “Difficulties in recruiting” (88% match in meaning)
• Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19
  “difficulty in recruiting” (88% match in meaning)
• Validating the Effect og Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum
  “Recruiting difficulties” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.